Clinical Trial Update: LEV102 Topical Gel in Acquired Blepharoptosis [Phase 1, Phase 2]

View source ↗

Summary

LEV102 topical gel from Levation Pharma completed Phase 1/2 trials for acquired blepharoptosis, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Blepharoptosis

Drugs mentioned

• LEV102

Snippet

Sponsor: Levation Pharma, Ltd. | Conditions: Acquired Blepharoptosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-11-13